Bankruptcy judge begins review of contentious Purdue Pharma's $10 billion settlement plan
Purdue Pharma's bankruptcy has entered a crucial stage as Judge Robert Drain holds a hearing to decide whether to approve the OxyContin maker's settlement plan. |!| New Haven
